ESMO 2017—my personal highlights

This article is not intended to be a comprehensive review of all highlights presented at the recent ESMO Annual Meeting, but rather a summary from a personal point of view in three very different fields of oncology. Breast cancer and lung cancer are traditionally in the focus of interest, and again,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiesewetter, Barbara, Dediu, Mircea, Bartsch, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2018
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862913/
https://www.ncbi.nlm.nih.gov/pubmed/29606982
http://dx.doi.org/10.1007/s12254-018-0385-1
_version_ 1783308309488467968
author Kiesewetter, Barbara
Dediu, Mircea
Bartsch, Rupert
author_facet Kiesewetter, Barbara
Dediu, Mircea
Bartsch, Rupert
author_sort Kiesewetter, Barbara
collection PubMed
description This article is not intended to be a comprehensive review of all highlights presented at the recent ESMO Annual Meeting, but rather a summary from a personal point of view in three very different fields of oncology. Breast cancer and lung cancer are traditionally in the focus of interest, and again, relevant new data were presented. The third part of this overview is focused on novel treatment strategies in malignant lymphoma, a field that is also quickly evolving and traditionally underrepresented at meetings dealing with solid cancers.
format Online
Article
Text
id pubmed-5862913
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-58629132018-03-28 ESMO 2017—my personal highlights Kiesewetter, Barbara Dediu, Mircea Bartsch, Rupert Memo Comment This article is not intended to be a comprehensive review of all highlights presented at the recent ESMO Annual Meeting, but rather a summary from a personal point of view in three very different fields of oncology. Breast cancer and lung cancer are traditionally in the focus of interest, and again, relevant new data were presented. The third part of this overview is focused on novel treatment strategies in malignant lymphoma, a field that is also quickly evolving and traditionally underrepresented at meetings dealing with solid cancers. Springer Vienna 2018-02-16 2018 /pmc/articles/PMC5862913/ /pubmed/29606982 http://dx.doi.org/10.1007/s12254-018-0385-1 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Comment
Kiesewetter, Barbara
Dediu, Mircea
Bartsch, Rupert
ESMO 2017—my personal highlights
title ESMO 2017—my personal highlights
title_full ESMO 2017—my personal highlights
title_fullStr ESMO 2017—my personal highlights
title_full_unstemmed ESMO 2017—my personal highlights
title_short ESMO 2017—my personal highlights
title_sort esmo 2017—my personal highlights
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862913/
https://www.ncbi.nlm.nih.gov/pubmed/29606982
http://dx.doi.org/10.1007/s12254-018-0385-1
work_keys_str_mv AT kiesewetterbarbara esmo2017mypersonalhighlights
AT dediumircea esmo2017mypersonalhighlights
AT bartschrupert esmo2017mypersonalhighlights

Ejemplares similares